Chesnara (CSN) - Net Assets
Based on the latest financial reports, Chesnara (CSN) has net assets worth GBX293.30 Million GBX (≈ $35.69K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX13.51 Billion ≈ $1.64 Million USD) and total liabilities (GBX13.22 Billion ≈ $1.61 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Chesnara strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX293.30 Million |
| % of Total Assets | 2.17% |
| Annual Growth Rate | 5.8% |
| 5-Year Change | -35.45% |
| 10-Year Change | 6.52% |
| Growth Volatility | 14.42 |
Chesnara - Net Assets Trend (2001–2024)
This chart illustrates how Chesnara's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Chesnara stock valuation.
Annual Net Assets for Chesnara (2001–2024)
The table below shows the annual net assets of Chesnara from 2001 to 2024. Also explore CSN net assets growth trend to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | GBX314.40 Million ≈ $38.25K |
-12.64% |
| 2023-12-31 | GBX359.90 Million ≈ $43.79K |
+8.04% |
| 2022-12-31 | GBX333.12 Million ≈ $40.53K |
-27.29% |
| 2021-12-31 | GBX458.17 Million ≈ $55.75K |
-5.93% |
| 2020-12-31 | GBX487.07 Million ≈ $59.26K |
+2.43% |
| 2019-12-31 | GBX475.49 Million ≈ $57.85K |
+6.70% |
| 2018-12-31 | GBX445.62 Million ≈ $54.22K |
-1.34% |
| 2017-12-31 | GBX451.66 Million ≈ $54.95K |
+14.76% |
| 2016-12-31 | GBX393.56 Million ≈ $47.88K |
+33.34% |
| 2015-12-31 | GBX295.16 Million ≈ $35.91K |
+5.86% |
| 2014-12-31 | GBX278.83 Million ≈ $33.93K |
+12.84% |
| 2013-12-31 | GBX247.10 Million ≈ $30.07K |
+13.17% |
| 2012-12-31 | GBX218.35 Million ≈ $26.57K |
+4.38% |
| 2011-12-31 | GBX209.19 Million ≈ $25.45K |
+2.91% |
| 2010-12-31 | GBX203.27 Million ≈ $24.73K |
+27.23% |
| 2009-12-31 | GBX159.77 Million ≈ $19.44K |
+26.43% |
| 2008-12-31 | GBX126.37 Million ≈ $15.38K |
+0.46% |
| 2007-12-31 | GBX125.78 Million ≈ $15.30K |
+10.09% |
| 2006-12-31 | GBX114.25 Million ≈ $13.90K |
+5.53% |
| 2005-12-31 | GBX108.27 Million ≈ $13.17K |
+36.28% |
| 2004-12-31 | GBX79.44 Million ≈ $9.67K |
+0.89% |
| 2003-12-31 | GBX78.74 Million ≈ $9.58K |
-12.12% |
| 2002-12-31 | GBX89.60 Million ≈ $10.90K |
+4.19% |
| 2001-12-31 | GBX86.00 Million ≈ $10.46K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Chesnara's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 200.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | GBX136.50 Million | 43.42% |
| Common Stock | GBX7.50 Million | 2.39% |
| Other Comprehensive Income | GBX27.90 Million | 8.87% |
| Other Components | GBX142.50 Million | 45.32% |
| Total Equity | GBX314.40 Million | 100.00% |
Chesnara Competitors by Market Cap
The table below lists competitors of Chesnara ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Aspire BioPharma, Inc.
NASDAQ:ASBP
|
$10.09 Million |
|
Metallis Resources Inc.
V:MTS
|
$10.09 Million |
|
Globe Kita Terang Tbk PT
JK:GLOB
|
$10.09 Million |
|
Ostin Technology Group Co Ltd
NASDAQ:OST
|
$10.11 Million |
|
Voltaic Strategic Resources Ltd
AU:VSR
|
$10.08 Million |
|
IZOTROPIC CORP.
F:1R3
|
$10.08 Million |
|
Titan Logix Corp.
V:TLA
|
$10.08 Million |
|
Companhia de Fiacao e Tecidos Cedro Cachoeira
SA:CEDO3
|
$10.08 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Chesnara's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 359,900,000 to 314,400,000, a change of -45,500,000 (-12.6%).
- Net income of 3,900,000 contributed positively to equity growth.
- Dividend payments of 36,500,000 reduced retained earnings.
- Other comprehensive income increased equity by 21,399,999.
- Other factors decreased equity by 34,299,999.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX3.90 Million | +1.24% |
| Dividends Paid | GBX36.50 Million | -11.61% |
| Other Comprehensive Income | GBX21.40 Million | +6.81% |
| Other Changes | GBX-34.30 Million | -10.91% |
| Total Change | GBX- | -12.64% |
Book Value vs Market Value Analysis
This analysis compares Chesnara's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 175.01x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 385.96x to 175.01x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | GBX0.93 | GBX359.00 | x |
| 2004-12-31 | GBX0.94 | GBX359.00 | x |
| 2005-12-31 | GBX1.12 | GBX359.00 | x |
| 2006-12-31 | GBX1.09 | GBX359.00 | x |
| 2007-12-31 | GBX1.20 | GBX359.00 | x |
| 2008-12-31 | GBX1.21 | GBX359.00 | x |
| 2009-12-31 | GBX1.57 | GBX359.00 | x |
| 2010-12-31 | GBX1.98 | GBX359.00 | x |
| 2011-12-31 | GBX1.82 | GBX359.00 | x |
| 2012-12-31 | GBX1.90 | GBX359.00 | x |
| 2013-12-31 | GBX2.15 | GBX359.00 | x |
| 2014-12-31 | GBX2.41 | GBX359.00 | x |
| 2015-12-31 | GBX2.33 | GBX359.00 | x |
| 2016-12-31 | GBX3.07 | GBX359.00 | x |
| 2017-12-31 | GBX3.00 | GBX359.00 | x |
| 2018-12-31 | GBX2.96 | GBX359.00 | x |
| 2019-12-31 | GBX3.15 | GBX359.00 | x |
| 2020-12-31 | GBX3.22 | GBX359.00 | x |
| 2021-12-31 | GBX3.02 | GBX359.00 | x |
| 2022-12-31 | GBX2.22 | GBX359.00 | x |
| 2023-12-31 | GBX2.37 | GBX359.00 | x |
| 2024-12-31 | GBX2.05 | GBX359.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Chesnara utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.24%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.23%
- • Asset Turnover: 0.13x
- • Equity Multiplier: 40.57x
- Recent ROE (1.24%) is below the historical average (10.41%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | -13.68% | -282.06% | 0.00x | 12.54x | GBX-18.64 Million |
| 2004 | 6.49% | 2.46% | 0.21x | 12.87x | GBX-2.79 Million |
| 2005 | 17.19% | 5.17% | 0.17x | 19.18x | GBX7.79 Million |
| 2006 | 16.85% | 6.51% | 0.14x | 18.64x | GBX7.83 Million |
| 2007 | 20.22% | 11.38% | 0.11x | 16.23x | GBX12.86 Million |
| 2008 | 15.84% | 16.28% | 0.07x | 13.29x | GBX7.38 Million |
| 2009 | 28.76% | 10.04% | 0.16x | 18.28x | GBX29.96 Million |
| 2010 | 14.67% | 6.53% | 0.09x | 23.83x | GBX9.49 Million |
| 2011 | 12.27% | 0.00% | 0.00x | 21.47x | GBX4.75 Million |
| 2012 | 12.80% | 5.60% | 0.11x | 21.30x | GBX6.11 Million |
| 2013 | 19.98% | 6.71% | 0.14x | 21.19x | GBX24.65 Million |
| 2014 | 9.17% | 4.37% | 0.11x | 19.14x | GBX-2.31 Million |
| 2015 | 13.48% | 13.61% | 0.05x | 18.19x | GBX10.27 Million |
| 2016 | 8.96% | 5.29% | 0.11x | 15.49x | GBX-4.08 Million |
| 2017 | 17.37% | 9.37% | 0.10x | 18.69x | GBX33.27 Million |
| 2018 | 5.41% | 104.60% | 0.00x | 17.54x | GBX-20.44 Million |
| 2019 | 16.64% | 5.49% | 0.18x | 17.12x | GBX31.59 Million |
| 2020 | 4.35% | 3.34% | 0.07x | 18.18x | GBX-27.52 Million |
| 2021 | 5.96% | 1.82% | 0.16x | 20.57x | GBX-18.52 Million |
| 2022 | -10.12% | 0.00% | -0.06x | 33.45x | GBX-67.01 Million |
| 2023 | 5.20% | 1.81% | 0.09x | 33.70x | GBX-17.29 Million |
| 2024 | 1.24% | 0.23% | 0.13x | 40.57x | GBX-27.54 Million |
Industry Comparison
This section compares Chesnara's net assets metrics with peer companies in the Insurance - Life industry.
Industry Context
- Industry: Insurance - Life
- Average net assets among peers: $-1,589,079,736
- Average return on equity (ROE) among peers: 7.60%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Chesnara (CSN) | GBX293.30 Million | -13.68% | 45.06x | $10.09 Million |
| Ecclesiastical Insurance Office plc (ELLA) | $-7.76 Billion | 0.00% | 0.00x | $5.91 Million |
| Hansard Global Plc (HSD) | $20.80 Million | 25.00% | 64.74x | $838.99K |
| Phoenix Group Holdings PLC (PHNX) | $573.00 Million | 5.41% | 0.03x | $93.45 Million |
| Prudential plc (PRU) | $805.04 Million | 0.00% | 34.79x | $309.41 Million |
About Chesnara
Chesnara plc, together with its subsidiaries, operates in life assurance and pension businesses primarily in the United Kingdom and Sweden. It operates through UK, Movestic, Waard Group, Scildon, and Other segments. The company underwrites life, health, accident, and disability cover by providing savings and pensions products to meet future financial needs; and provides a portfolio of investment … Read more